Omega Therapeutics, Inc. (NASDAQ:OMGA – Get Rating)’s share price traded up 5.9% on Monday . The company traded as high as $8.11 and last traded at $8.11. 50,382 shares were traded during mid-day trading, a decline of 44% from the average session volume of 90,671 shares. The stock had previously closed at $7.66. Wall Street […]
Should You Buy or Sell Omega Therapeutics Stock? Get The Latest OMGA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Omega Therapeutics (NASDAQ:OMGA – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCBD – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership. Earnings & Valuation This table compares Omega Therapeutics and […]
Omega Therapeutics, Inc. (NASDAQ:OMGA – Get Rating) Director Richard A. Young sold 5,000 shares of Omega Therapeutics stock in a transaction dated Thursday, April 6th. The shares were sold at an average price of $8.00, for a total value of $40,000.00. Following the completion of the sale, the director now owns 749,118 shares of the […]
HC Wainwright reissued their buy rating on shares of Omega Therapeutics (NASDAQ:OMGA – Get Rating) in a research note published on Friday morning, Benzinga reports. The firm currently has a $11.00 price target on the stock. Other equities research analysts have also recently issued research reports about the stock. Jonestrading began coverage on shares of […]